glp 1 law suit A federal judge on Wednesday dismissed part of Eli Lilly's lawsuit against the Houston-based Empower Pharmacy — the latest development in the pharmaceutical giant's bid to curb sales of cheaper, less-regulated versions GLP-1 Medications | Daniel Stark

In its Q4 2025 earnings call, Andrew Dudum, co-founder and CEO, noted that the company's "weight loss offering reached $100 million revenue run rate in less than seven months after launch." This speed outstripped its other offerings, which took "three and sometimes even four years to (inaudible) $100 million in annual revenue." This revenue boost occurred despite the significant blowback Hims & Hers faced when it initially announced plans to advertise and sell compounded versions of FDA-approved GLP-1 medications

Experts have known for years that stopping GLP-1s results in weight gain

Jill Carnahan, MD Wow, that was an incredible whirlwind

$18.55 $26.50 Wellness Multiple $18.55 Wellness Multiple On Sale

Introducing Ultra 9X, the highest-potency upgraded version of the original Ultra X

Real-world impact of GLP-1 receptor agonists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center